ArticleNPJ genomic medicine2021

HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.

Mahdi Golkaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.